Hubei Biocause Pharmaceutical Co., Ltd. (SZSE:000627) agreed to acquire 60% stake in Huarui Insurance Sales Co.,Ltd. for approximately CNY 150 million on September 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 CNY | -4.41% | -9.30% | -31.34% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.34% | 1.33B | |
+12.07% | 80.02B | |
+7.09% | 50.2B | |
+5.91% | 49.81B | |
+20.83% | 46.42B | |
+13.02% | 42.09B | |
+24.78% | 40.35B | |
-2.04% | 28.58B | |
-9.80% | 26.95B | |
+25.68% | 26.09B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Hubei Biocause Pharmaceutical Co., Ltd. agreed to acquire 60% stake in Huarui Insurance Sales Co.,Ltd. for approximately CNY 150 million.